• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Bot Image's ProstatID AI Software Gains FDA Nod

    Researchers Develop Deep Learning Model for Eye Disorder Screening

    Medidata Unveils New Tech to Improve Clinical Trial Oversight

    BD, Direct Relief, NACHC Award $1M Grant for Health Equity

    Domestic Production Key to India's Medtech Manufacturing Success
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Parylene Coatings for Medical Device Technologies

    The Big Shift: Nearshoring Trends in Medtech Manufacturing

    OEMs Seek Molders Offering Timely Techniques

    Robotic Surgery: Cutting Through to the Latest

    Packaging, Sterilization Considerations Go Part and Parcel with Product Development
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Cooling and Melting the Pain Away

    What Are the Fundamentals of Go-To-Market Strategy in Medical Devices?

    Minding the Gap: How Harmonizing Quality Systems Pays Off

    Building Strong Partnerships Between Medtech and Surgeon-Learning Platforms

    Four Key Considerations for OEMs Transferring a Product Program
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Trademark Plastics Inc.

    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Xact Wire EDM Corp.
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    The Importance of Building Successful Supplier Relationships

    The Benefits of Outsourcing Innovation in Medtech Manufacturing

    Patching Healthcare Cybersecurity Risks in the Internet of Medical Things

    Leveraging Open Healthcare Data Standards to Improve Medical Device Manufacturing

    3 Ways Privacy-Enhancing Technology Will Improve Medical Products Innovation
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Trademark Plastics Inc.

    Cirtec Medical

    Arthur G. Russell Co. Inc., The

    JBC Technologies

    Xact Wire EDM Corp.
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Features

    MDR/IVDR Rollout and Challenges—2021 Year in Review

    With the MDR sprint mercifully behind them, medtech firms must now turn their attention to the next leg of Europe’s revamped regulatory relay: the IVDR.

    MDR/IVDR Rollout and Challenges—2021 Year in Review
    Michael Barbella , Managing Editor11.10.21
    It’s been a long, mad dash to the finish line these past few years, but it’s finally over.
     
    The race has ended, the victory laps complete.
     
    The track is empty.
     
    Time to focus on the next race, the countdown for which has already begun.
     
    With the MDR sprint mercifully behind them, medtech organizations must now turn their attention to the next leg of Europe’s revamped regulatory relay: the IVDR.
     
    The global MDR run officially ended on May 26, a year later than originally planned, courtesy of the COVID-19 pandemic. The additional time was both a boon and bane for the industry, helping countless companies meet the new deadline but failing to resolve significant challenges with the regulations’ implementation.
     
    “No matter where you’re standing, the MDR ship has sailed....the date of MDR application has come, it is the only pathway in Europe now for certifying medical devices,” Oliver Bisazza, director, Regulations & Industrial Policy, MedTech Europe, told a MedTech Conference panel earlier this fall. “We really are now in MDR chapter two. The ship has sailed and we need to keep it afloat. I don’t think that ship is necessarily going to sink tomorrow, I think it is sailing, but we are keeping our eyes on a number of things to assess whether that ship is going to stay healthily afloat in the years and decades to come.”
     
    Buoyancy maintenance, in fact, will largely depend on completion of the MDR’s basic infrastructure. The ship left port this past spring without enough Competent Authorities (CA) and Notified Bodies (NB) crew, which have made it challenging to certify both combination products and new, innovative medical devices in a timely manner.
     
    “There have been 22 Notified Bodies designated so far for the MDR, and that means some companies may not find any suitable Notified Body available after a certain time,” noted Michel Marboeuf, Stryker Corp.’s senior director, Regulatory Affairs Corporate. “Moving from one Notified Body to another might not be possible, and some Notified Bodies have been designated for a limited scope. Everyone needs to go through this process and basically, the supply is not matching the demand. Some Notified Bodies do not have the necessary expertise or capacity to respond or review submissions. This is definitely one of the challenges of the system.”
     
    Another challenge aboard the S.S. MDR is the lack of rule harmonization and definitive agreements/mandates between the EU and other countries, particularly Switzerland, a key medical device supplier to the continent. Also complicating shipboard life is the unpredictable recognition of international MDR certifications.
     
    Resolving these challenges is critical to ensuring the MDR ship remains afloat and capable of fostering product innovation under the new rules, industry watchdogs claim. Viable solutions also will help the medtech sector avoid potential device shortages, though regulatory officials expect some products to be lost in the proverbial shuffle.
     
    “I think it’s important to know that there are challenges and it’s hard to come up over the new barrier, but I have to remind all that there is a reason [for] the new rules,” Thomas Wejs Moller, chair of Competent Authorities for Medical Devices at the Danish Medicines Agency, reminded his fellow MedTech Conference panelists. “We needed the new rules. The rules we had were more than 20-25 years old, and with the [medical device] development we’ve seen we needed to strengthen the whole thing a little bit. I think it’s important to acknowledge that it’s needed to lift the whole area up to a new level. There will be consequences for companies maybe in terms of some market adjustments—it’s a little hard to say, really. We can do our best to make it as smooth as possible but there will always be products that will not come into the new system because, well, there is a reason why it’s been lifted a little bit.”
     
    Understandably so, but medtech executives are concerned the reasoning will disproportionately impact legacy products, orphan medical devices, and new technologies that lack ample clinical evidence to support their efficacy. The new regulations also could possibly price numerous small and medium-sized device firms out of the market, as these organizations anticipate sacrificing a sizable portion of their profits on MDR certification.
     
    Precise cost estimates for the certification process are difficult to calculate because the system’s basic infrastructure is still in flux. However, most medtech companies (44 percent) expect to devote between 1 percent and 5 percent of their annual revenue toward MDR compliance, a Climedo Health survey concluded earlier this spring. Nearly one-third (31 percent) anticipate a higher price tag (between 5 percent and 10 percent of their annual revenue), and 13 percent of poll respondents fear spending more than 10 percent of their profits on MDR credentialing.
     
    “In general, the MDR ship is sailing. But there are two things I see as a consultant,” noted Bernhard Bichsel, senior consultant at ISS AG, Integrated Science Services, a Swiss consultancy providing embedded software development, regulatory, and clinical evaluation report writing support to medical device companies. “One, it’s slowing down innovation. We are helping startup companies and usually they don’t make it to market or they start with the U.S. first. This is especially true for software companies. The second thing, which bothers me a little bit as a citizen, is the issue of [potential] shortages. I have manufacturers that I’m helping to reduce their product portfolio. Because of the new regulations, it’s just too expensive to scale all their products up to the new requirements, so I focus on the blockbusters. The orphan medical devices are especially at risk, at least some element of them, anyway. I think people will see these disturbances in the market in the future.”
     
    In the very near future, actually: Monumental disturbances are looming next spring for the in-vitro diagnostics sector, which lacks the capacity to process the tidal wave of tests needing new (or renewed) NB certificates under Europe’s latest IVD Regulation (IVDR).
     
    A MedTech Europe report estimates that 78 percent of diagnostics currently on the market will require a certificate, compared to only 8 percent under the previous (existing) mandate (IVDD). Manufacturers are hoping to transition up to 31,118 IVDs to the new regulation, compared with 39,844 diagnostics under the present rule, leaving a 22 percent potential shortfall in available devices, the report states.
     
    That shortfall, according to regulatory officials, is directly attributable to the severe dearth of designated Notified Bodies. The IVDR Notified Bodies pool is in worse shape than its medical device counterpart, with just six NBs commissioned thus far for diagnostics, most of which were designated over the summer.
     
    “We are now only less than nine months before the date of application—a hard stop for the majority of IVDs with no grace period or (for practical reasons) sell-off provision to rely on,” states MedTech Europe’s report, dated Sept. 8 (and co-authored by Bisazza). “...much time and effort is still needed to ensure that EU IVD medical tests do not fall off a cliff-edge. The lack of IVDR infrastructure is the main reason stated for this expected and avoidable loss. In the early days of the new regulation, it had seemed possible to create Notified Body capacity, the guidance, and other infrastructure, but with the imminent date of application, there is no longer enough time.”
     
    A growing chorus of healthcare professionals agree, and have called upon the European Medicines Agency to delay the IVDR’s implementation, slated for May 26, 2022. A deferral, several trade groups and companies contend, is the only way to prevent serious patient care disruptions, particularly amongst those undergoing targeted cancer treatment.
     
    Extra time also would provide cancer patients with uninterrupted access to biomarker testing, enabling up to 65,000 non-small cell lung and ovarian cancer patients annually to receive the testing needed to undergo targeted therapy for their diseases.
     
    “We need to postpone the IVDR. The system itself is not ready,” Bichsel said. “It’s either going to force manufacturers into a gray zone, or force products out of the market, which could have bad effects on patients. There are a number of ways to save it, but if you don’t change anything we will not be ready at the time [of application]. The Notified Bodies capacity is the problem.”
     
    Indeed, NB deficiency is a problem, but it’s not the only defect in the IVDR’s hull. Other structural weaknesses rest with EUDAMED, expert panels, EU reference labs, and (inadequate) guidance, though none are as efficient as the latter in breeding inconsistent decision-making amongst manufacturers, NBs, and Competent Authorities. MedTech Europe’s report cites several key areas of missing guidance, including performance evaluations, OEM products, Class D scrutiny, companion diagnostics, and clinical trial assays (clarity is needed on precisely which tests used in new drug trials will be subject to IVDR mandates).
     
    Realizing such an ill-equipped ship would endanger its passengers (and crew), the European Commission in mid-October proposed a progressive rollout of the IVDR to avoid product shortages. Next May’s date still applies to CE-marked devices with no NB involvement or “new” products lacking an NB certificate or declaration of conformity, but higher-risk Class C and D diagnostics (HIV, hepatitus, influenza tests) must be fully compliant by May 2025 and 2026, respectively. Lower-risk Class A and B sterile devices, meanwhile, must transition to the new rules by May 2027.
     
    “The COVID-19 pandemic has shown how essential it is to have accurate diagnostics and a robust regulatory framework for in-vitro medical devices,” Stella Kyriakides, Health and Food Safety Commissioner, said in an Oct. 14 prepared statement. “Shortages at this point in time are unthinkable. The pandemic has imposed unprecedented challenges also for our medical devices industry. With more time to prepare for the application of the EU new rules, we will ensure there is a continuous supply of essential in-vitro diagnostic medical devices on the market, while not compromising on safety. I call on all manufacturers to prepare for certification under the new Regulation as soon as possible and not wait until the end of the transition period.”
     
    Moller, however, opposes a delay, contending the new regulations are imperative to better patient care.
     
    “Why is the IVDR coming into place? Because it is a very underregulated area in Europe,” he said. “Being a Competent Authority during the COVID-19 crisis, and being in charge of antigen tests and PCR tests in Denmark over the last year and a half, I can tell you the things we saw coming in for professional use with a CE mark from all over the world—the quality was not necessarily there. This is an area where we all need to be better—as taxpayers, as patients, and as citizens. I think we would all prefer [diagnostics] to be better. That being said, I know there are challenges here. But I think it’s important to get the IVDR ship sailing and get the destination port locked in so the ship knows where it’s sailing and that clarity, or direction is there. That’s the best thing that can happen for all of us.”
     
    Apart from a deadline extension, of course.
     
    Be sure to review the other portions of the 2021 Year in Review feature:

    Ransomware Attacks Push Cybersecurity into the Spotlight
     
    Supply Chain Struggles for Medtech Manufacturers
     
    M&A Accelerates During the Pandemic
     

    Loading, Please Wait..

    Trending
    • U.K. Strengthens Medical Device Regulations
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • How Are Hypodermic Needles Made?
    • Microneedle Patch Glucose Monitor Proves Virtually Painless And More Accurate
    • The Future Of Biomedical Engineering Advancements
    Breaking News
    • First Patient Cases Using Memic's Hominis Surgical System
    • Bot Image's ProstatID AI Software Gains FDA Nod
    • Researchers Develop Deep Learning Model for Eye Disorder Screening
    • Medidata Unveils New Tech to Improve Clinical Trial Oversight
    • BD, Direct Relief, NACHC Award $1M Grant for Health Equity
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Parylene Coatings for Medical Device Technologies
    • Nearshoring Trends in Medtech Manufacturing
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Flower Pollen Extract Benefits Women’s Urinary Incontinence, Study Finds
    3i Solutions Announces New Leadership Positions
    INS Nutra Opens Gummy Manufacturing Facility
    Coatings World

    Latest Breaking News From Coatings World

    PPG’s New Paint for a New Start Initiative Transforms Ecole & Collège Saint Joseph School in France
    KRATON Receives Platinum Rating from EcoVadis for Sustainability Management System
    Lanxess' Entire Value Chain to Become Climate-Neutral
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Bot Image's ProstatID AI Software Gains FDA Nod
    Researchers Develop Deep Learning Model for Eye Disorder Screening
    Medidata Unveils New Tech to Improve Clinical Trial Oversight
    Contract Pharma

    Latest Breaking News From Contract Pharma

    MilliporeSigma to Provide Full Viral Vector Offering with Launch of VirusExpress 293
    Charles River Receives EMA Approval to Produce Allogeneic Cell Therapy
    Romaco Group Taps Jens Torkel as VP, Sales & Customer Service
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Fashion Designer Issey Miyake Dies
    Cetaphil Announces Clean Formulas & Commits to Sustainability
    Batiste Kicks Off Partnership with Fitness Brand
    Happi

    Latest Breaking News From Happi

    Hallstar To Purchase Lanxess’ Polymer Additives Production Site in Greensboro, NC
    Uber and The Body Shop Expand On-Demand Delivery Partnership Nationwide
    Australia-Based Teeth Whitening Technology Leader White Glo Enters US Market
    Ink World

    Latest Breaking News From Ink World

    Xerox Board of Directors Names Steven Bandrowczak as CEO
    ALTANA AG to Sell Its Stake in dp polar to 3D Systems
    Weekly Recap: Zeller+Gmelin, Epple Druckfarben Lead This Week’s News Stories
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Rotocontrol EMT brings hybrid printing and finishing to Labelexpo Americas
    Avery Dennison debuts next generation AD CleanFlake technology
    Eukalin acquires Adhesives Specialists
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Weekly Recap: A New Day for Hygiene, Glatfelter Reports Q2 Results & More
    Dyper Achieves B Corp Certification
    Edgewell’s Sales Grow
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AxioMed LLC Submits Module III to FDA for Lumbar Viscoelastic Disc Replacement
    Extremity Medical Developing MIS Techniques for Foot and Ankle
    OSSIO Rolls Out OSSIOfiber Suture Anchors in U.S.
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    CdTe Accelerator Consortium Aims to Reduce Costs, Speed Deployment
    Universal Display Announces Retirement Plans of CFO Sidney D. Rosenblatt
    Fast Company Names Zebra Technologies to 2022 Best Workplaces for Innovators

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login